Ratnakar Securities Pvt. Ltd.

RPG LIFE SCIENCES LTD.

NSE : RPGLIFEBSE : 532983ISIN CODE : INE105J01010Industry : Pharmaceuticals & DrugsHouse : RPG Enterprises

BSE2299.3523.65 (+1.04 %)

PREV CLOSE ( ) 2275.70

OPEN PRICE ( ) 2377.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1800

TODAY'S LOW / HIGH ( )2284.60 2377.00

52 WK LOW / HIGH ( )1210 2440

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 2007

Management Info

Harsh Goenka - Chairman Yugal Sikri - Managing Director

Registered Office

Address R P G House , 463,Ceat Mahal,Dr. Annie Besant Road, Worli,
Mumbai,
Maharashtra-400030

Phone 022 - 24981650 / 24986375

Email info@rpglifesciences.com

Website www.rpglifesciences.com

Registrars Details

Link Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

08Aug Rpg Life Sciences informs about analys
Pursuant to Regulation 30 read with Para A of Schedule Ill of the SEBI (..

20Jul Rpg Life Sciences informs about press
Rpg Life Sciences has informed that it enclosed a copy of press release..

12Mar RPG Life Sciences signs Share Subscrip
RPG Life Sciences has signed Share Subscription and Shareholders' agreem..

20Dec RPG Life Sciences informs about detail
RPG Life Sciences has enclosed intimation of the loss of share certifica..

19Oct RPG Life Sciences to execute power del
RPG Life Sciences has received approval for execution of Power Delivery..

Financials

in Millions

	QTR Jun 24	ANNUAL 24
Net Profit	267.6	876.6
Gross Profit	360	1178.4
Operating Profit	414.4	1353.6
Net Sales	1654.2	5820.5

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE) 12806.30 (2.56%)	M.Cap ( in Cr)16430.34
Sanofi India (BSE) 7212.90 (0.85%)	M.Cap ( in Cr)16611.76
Samrat Pharmachem (BSE) 632.30 (9.61%)	M.Cap ( in Cr)195.36
Strides Pharma Scien (BSE) 1392.10 (2.85%)	M.Cap ( in Cr)12801.50
Hester Biosciences (BSE) 2437.40 (1.49%)	M.Cap ( in Cr)2073.46

Shareholding Pattern

	PROMOTERS	72.81%
	NON-INSTITUTION	23.43%
	MUTUAL FUNDS/UTI	1.65%
	FI/BANKS/INSURANCE	0.52%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
WOC Pharma and Heal...	1.55
Mirae Asset Multica...	1.38
Motilal Oswal BSE H...	0.07

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

RPG LIFE SCIENCES LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES